Zhejiang Tianyu Pharmaceutical Co Ltd (300702.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE1000034X1

Price
20.24 CNY
Market cap
7.04 bn CNY
P/E (2025)
50.41
P/S (2025)
2.30
Dividend yield
0.25 %
Net margin
4.56 %
Return on equity (ROE)
3.84 %
Return on assets (ROA)
2.12 %

Zhejiang Tianyu Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue2.63 bn CNY3.06 bn CNY
Gross profit869.86 m CNY1.14 bn CNY
Operating income84.87 m CNY304.40 m CNY
EBIT111.10 m CNY201.73 m CNY
Net income55.94 m CNY139.71 m CNY
Diluted EPS – continuing operations0.16 CNY0.40 CNY

Full history since 2013, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Zhejiang Tianyu Pharmaceutical Co Ltd

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-allergic, anticancer, anti-fungal, anti-epileptic, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It also provides fine chemicals and CDMO services. The company was founded in 1993 and is headquartered in Taizhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.